• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Apogee Therapeutics, Inc. - Common Stock (NQ:APGE)

    134.21 +0.21 (+0.15%)
    Streaming Delayed Price Updated: 3:08 PM EDT, Jul 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 592,283
    Open 134.06
    Bid (Size) 134.20 (600)
    Ask (Size) 134.21 (400)
    Prev. Close 134.00
    Today's Range 134.01 - 134.24
    52wk Range 34.34 - 134.32
    Shares Outstanding 56,367,802
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? ↗
    There's no need to panic. 
    Via The Motley Fool
    News headline image
    My 2 Favorite Dividend Kings to Buy Right Now ↗
    They can help stabilize your portfolio in these otherwise volatile times. 
    Via The Motley Fool
    Topics Intellectual Property

    Performance

    YTD
    +77.1%
    +77.1%
    1 Month
    +1.2%
    +1.2%
    3 Month
    +47.6%
    +47.6%
    6 Month
    +63.6%
    +63.6%
    1 Year
    +243.1%
    +243.1%

    More News

    Read More
    News headline image
    Halper Sadeh LLC is Investigating Whether NEE, CRBG, RMAX, APGE are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    What This Apogee Insider Move Might Mean After a 247% Stock Run ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    The Dividend ETF Quietly Outperforming the S&P 500 ↗
    Via The Motley Fool
    Topics ETFs Stocks
    News headline image
    Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders
    From Ademi LLP
    Via GlobeNewswire
    News headline image
    This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Halper Sadeh LLC is Investigating Whether APGE, LPRO, HUN, AVNS are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Why AbbVie Stock Jumped Today ↗
    Via The Motley Fool
    News headline image
    AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? ↗
    Via The Motley Fool
    News headline image
    Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer ↗
    Via The Motley Fool
    Topics Stocks
    Top movers analysis one hour before the close of the markets on 2026-06-22: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Which stocks are moving on Monday? ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    APGE Stock Alert: Halper Sadeh LLC is Investigating Whether Apogee Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    These stocks that are showing activity before the opening bell on Monday. ↗
    Via Chartmill
    News headline image
    Apogee Therapeutics Maps Phase 3 Push for Zumilokibart, Backed by Blackstone Funding ↗
    Via MarketBeat
    Topics Initial Public Offering
    News headline image
    Apogee Therapeutics Readies Zumi for Phase 3 With Blackstone Backing ↗
    Via MarketBeat
    Topics Initial Public Offering
    News headline image
    Apogee Therapeutics to Participate in Upcoming June Conferences
    From Apogee Therapeutics
    Via GlobeNewswire
    News headline image
    Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart
    From Apogee Therapeutics
    Via GlobeNewswire
    News headline image
    Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
    From Apogee Therapeutics
    Via GlobeNewswire

    Frequently Asked Questions

    Is Apogee Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Apogee Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Apogee Therapeutics, Inc. - Common Stock trade on?
    Apogee Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Apogee Therapeutics, Inc. - Common Stock?
    The ticker symbol for Apogee Therapeutics, Inc. - Common Stock is APGE on the Nasdaq Stock Market
    What is the current price of Apogee Therapeutics, Inc. - Common Stock?
    The current price of Apogee Therapeutics, Inc. - Common Stock is 134.21
    When was Apogee Therapeutics, Inc. - Common Stock last traded?
    The last trade of Apogee Therapeutics, Inc. - Common Stock was at 07/20/26 03:08 PM ET
    What is the market capitalization of Apogee Therapeutics, Inc. - Common Stock?
    The market capitalization of Apogee Therapeutics, Inc. - Common Stock is 7.56B
    How many shares of Apogee Therapeutics, Inc. - Common Stock are outstanding?
    Apogee Therapeutics, Inc. - Common Stock has 8B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.